Press "Enter" to skip to content

FDA Grants Priority Review to GSK’s Zejula for Late Stage Ovarian Cancer – Ovarian Cancer News Today

admin 0

FDA Grants Priority Review to GSK’s Zejula for Late Stage Ovarian Cancer  Ovarian Cancer News Today

The FDA has given priority review to an application seeking to extend Zejula’s approval to women with late-stage ovarian cancer without BRCA mutations.

“ovarian cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *